- Home
- GERN vs CSIQ Comparison
GERN vs CSIQ Comparison
Compare GERN & CSIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- CSIQ
- Stock Information
- Founded
- GERN 1990
- CSIQ 2001
- Country
- GERN United States
- CSIQ Canada
- Employees
- GERN N/A
- CSIQ N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- CSIQ Semiconductors
- Sector
- GERN Health Care
- CSIQ Technology
- Exchange
- GERN Nasdaq
- CSIQ Nasdaq
- Market Cap
- GERN 823.0M
- CSIQ 746.1M
- IPO Year
- GERN 1996
- CSIQ 2006
- Fundamental
- Price
- GERN $1.24
- CSIQ $15.02
- Analyst Decision
- GERN Buy
- CSIQ Hold
- Analyst Count
- GERN 7
- CSIQ 8
- Target Price
- GERN $3.17
- CSIQ $11.77
- AVG Volume (30 Days)
- GERN 7.6M
- CSIQ 2.5M
- Earning Date
- GERN 11-06-2025
- CSIQ 11-13-2025
- Dividend Yield
- GERN N/A
- CSIQ N/A
- EPS Growth
- GERN N/A
- CSIQ N/A
- EPS
- GERN N/A
- CSIQ N/A
- Revenue
- GERN $164,447,000.00
- CSIQ $5,919,361,000.00
- Revenue This Year
- GERN $172.62
- CSIQ N/A
- Revenue Next Year
- GERN $56.87
- CSIQ $23.33
- P/E Ratio
- GERN N/A
- CSIQ N/A
- Revenue Growth
- GERN 11877.20
- CSIQ N/A
- 52 Week Low
- GERN $1.09
- CSIQ $6.57
- 52 Week High
- GERN $4.50
- CSIQ $17.07
- Technical
- Relative Strength Index (RSI)
- GERN 43.70
- CSIQ 55.74
- Support Level
- GERN $1.19
- CSIQ $13.76
- Resistance Level
- GERN $1.31
- CSIQ $15.58
- Average True Range (ATR)
- GERN 0.07
- CSIQ 1.22
- MACD
- GERN -0.01
- CSIQ -0.16
- Stochastic Oscillator
- GERN 17.31
- CSIQ 46.06
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.